Clinical Trials Logo

Post-Menopausal Osteoporosis clinical trials

View clinical trials related to Post-Menopausal Osteoporosis.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05332626 Active, not recruiting - Bone Loss Clinical Trials

Lactobacillus Acidophilus and Postmenopausal Osteoporosis Women

LaBon
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

This study aims to evaluate the effect of Lactobacillus acidophilus supplementation on calcium status and bone densitometry in postmenopausal women in a randomized, double-blind placebo-controlled study.

NCT ID: NCT01232647 Active, not recruiting - Clinical trials for Post-menopausal Osteoporosis

Vitamin K as Additive Treatment in Osteoporosis

VITKANDOP
Start date: April 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Vitamin K is thought to be important for bone health because it activates several proteins involved in bone formation. Poor dietary intake of vitamin K (mainly found in dark green leafy vegetables) is associated with bone loss and fractures. Giving supplements of the main dietary form of vitamin K (called K1) or another common form which our bodies make from K1(called MK4), to improve bone health have given mixed results. This confusion is thought to have arisen because these studies involved people who already had enough vitamin K or did not have osteoporosis. We want to test the hypothesis that treatment with bisphosphonates combined with vitamin K, in vitamin K deplete elderly women with osteoporosis, may offer additional benefit on skeletal metabolism and reduction of fracture risk. We want to test this by measuring vitamin K status in post-menopausal women with osteoporosis who are on the recommended treatment with a bisphosphonate and calcium/vitamin D supplements. Those with low vitamin K will then be recruited to study the effect of supplementation with either K1 or MK4.